- Home
- PHUN vs PDSB Comparison
PHUN vs PDSB Comparison
Compare PHUN & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- PDSB
- Stock Information
- Founded
- PHUN 2009
- PDSB 2005
- Country
- PHUN United States
- PDSB United States
- Employees
- PHUN N/A
- PDSB N/A
- Industry
- PHUN EDP Services
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- PHUN Technology
- PDSB Health Care
- Exchange
- PHUN Nasdaq
- PDSB Nasdaq
- Market Cap
- PHUN 89.7M
- PDSB 84.2M
- IPO Year
- PHUN N/A
- PDSB N/A
- Fundamental
- Price
- PHUN $4.38
- PDSB $1.92
- Analyst Decision
- PHUN Strong Buy
- PDSB Strong Buy
- Analyst Count
- PHUN 3
- PDSB 3
- Target Price
- PHUN $13.00
- PDSB $14.00
- AVG Volume (30 Days)
- PHUN 1.5M
- PDSB 403.5K
- Earning Date
- PHUN 11-07-2024
- PDSB 11-14-2024
- Dividend Yield
- PHUN N/A
- PDSB N/A
- EPS Growth
- PHUN N/A
- PDSB N/A
- EPS
- PHUN N/A
- PDSB N/A
- Revenue
- PHUN $3,537,000.00
- PDSB N/A
- Revenue This Year
- PHUN N/A
- PDSB N/A
- Revenue Next Year
- PHUN $93.33
- PDSB N/A
- P/E Ratio
- PHUN N/A
- PDSB N/A
- Revenue Growth
- PHUN N/A
- PDSB N/A
- 52 Week Low
- PHUN $2.85
- PDSB $1.53
- 52 Week High
- PHUN $24.50
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- PHUN 43.55
- PDSB 37.63
- Support Level
- PHUN $4.17
- PDSB $1.78
- Resistance Level
- PHUN $4.78
- PDSB $2.05
- Average True Range (ATR)
- PHUN 0.28
- PDSB 0.16
- MACD
- PHUN 0.05
- PDSB 0.02
- Stochastic Oscillator
- PHUN 25.01
- PDSB 27.94
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.